Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1

por Alghamri, Mahmoud S, Thalla, Rohit, Avvari, Ruthvik P, Dabaja, Ali, Taher, Ayman, Zhao, Lili, Ulintz, Peter J, Castro, Maria G, Lowenstein, Pedro R
Publicado 2020

G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy

por Alghamri, Mahmoud S., McClellan, Brandon L., Avvari, Ruthvik P., Thalla, Rohit, Carney, Stephen, Hartlage, Margaret S., Haase, Santiago, Ventosa, Maria, Taher, Ayman, Kamran, Neha, Zhang, Li, Faisal, Syed Mohd, Núñez, Felipe J., Garcia-Fabiani, María Belén, Al-Holou, Wajd N., Orringer, Daniel, Hervey-Jumper, Shawn, Heth, Jason, Patil, Parag G., Eddy, Karen, Merajver, Sofia D., Ulintz, Peter J., Welch, Joshua, Gao, Chao, Liu, Jialin, Núñez, Gabriel, Hambardzumyan, Dolores, Lowenstein, Pedro R., Castro, Maria G.
Publicado 2021